H-VLDVGDAYFSV-OH

Ref. 3D-PP42880

Informations sur le produit

• Nom: H-VLDVGDAYFSV-OH
• Synonymes: NH2-Val-Leu-Asp-Val-Gly-Asp-Ala-Tyr-Phe-Ser-Val-OH

Description

Peptide H-VLDVGDAYFSV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VLDVGDAYFSV-OH include the following: Quantification of CD8+ T Lymphocytes Responsive to Human Immunodeficiency Virus (HIV) Peptide Antigens in HIV-Infected Patients and Seronegative Persons at W Herr, U Protzer , AW Lohse, G Gerken - Journal of Infectious , 1998 - academic.oup.comhttps://academic.oup.com/jid/article-abstract/178/1/260/919828 Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase SH van der Burg , MR Klein , CJH van de Velde - Aids, 1995 - journals.lww.comhttps://journals.lww.com/aidsonline/abstract/1995/02000/Induction_of_a_primary_human_cytotoxic.2.aspx Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. SH Van Der Burg , MJ Visseren, RM Brandt - (Baltimore, Md.: 1950 , 1996 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/156/9/3308/29478 Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients C Shiu, CK Cunningham , T Greenough - Journal of , 2009 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00570-09

• Marque: Biosynth